blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1913024

EP1913024 - METHOD FOR THE PURIFICATION OF ALPHA-1 PROTEINASE INHIBITOR (a1PI) [Right-click to bookmark this link]
Former [2008/17]METHOD FOR THE PURIFCATION OF ALPHA-1 PROTEINASE INHIBITOR (a1PI)
[2009/19]
StatusNo opposition filed within time limit
Status updated on  19.03.2010
Database last updated on 30.09.2024
Most recent event   Tooltip07.10.2011Lapse of the patent in a contracting state
New state(s): CY, TR
published on 09.11.2011  [2011/45]
Applicant(s)For all designated states
Baxter International Inc.
One Baxter Parkway
Deerfield, IL 60015 / US
For all designated states
Baxter Healthcare SA
Hertistrasse 2
8304 Wallisellen / CH
[2008/17]
Inventor(s)01 / MATTHIESSEN, Peter
Vorgartenstrasse 129-143/1/5
A-1020 Vienna / AT
02 / BRACHTL, Gerald
Hellwagstrasse 4-8/6/22
A-1200 Vienna / AT
03 / TURECEK, Peter
Weidling Hauptstrasse 59g
A-3400 Klosterneuburg / AT
04 / SCHWARZ, Hans-Peter
Poetzleinsdorfer Strasse 50/9/2
1180 Vienna / AT
 [2009/20]
Former [2009/19]01 / MATTHIESSEN, Peter
Vorgartenstrasse 129-143/1/5
A-1020 Vienna / AT
02 / BRACHTL, Gerald
Hellwagstrasse 4-8/6/22
A-1200 Vienna / AT
03 / TURECEK, Peter
Weidling Hauptstrasse 59g
A-3400 Klosterneuburg / AT
04 / SCHWARZ, Hans-Peter
Poetzleinsdorfer Strasse 50/9/2
1180 Wienna / AT
Former [2008/17]01 / MATTHIESSEN, Peter
Vorgartenstrasse 129-143/1/5
A-1020 Vienna / AT
02 / BRACHTL, Gerald
Hellwagstrasse 4-8/6/22
A-1200 Vienna / AT
03 / TURECEK, Peter
Weidling Hauptstrasse 59g
A-3400 Klosterneuburg / AT
04 / SCHWARZ, Hans-Peter
Schindlergasse 32
A-1180 Wienna / AT
Representative(s)Müller-Boré & Partner Patentanwälte PartG mbB
Friedenheimer Brücke 21
80639 München / DE
[N/P]
Former [2008/17]Müller-Boré & Partner Patentanwälte
Grafinger Strasse 2
81671 München / DE
Application number, filing date06776720.209.08.2006
[2008/17]
WO2006EP07899
Priority number, dateUS2005020234911.08.2005         Original published format: US 202349
[2008/17]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2007017277
Date:15.02.2007
Language:EN
[2007/07]
Type: A1 Application with search report 
No.:EP1913024
Date:23.04.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 15.02.2007 takes the place of the publication of the European patent application.
[2008/17]
Type: B1 Patent specification 
No.:EP1913024
Date:13.05.2009
Language:EN
[2009/20]
Search report(s)International search report - published on:EP15.02.2007
ClassificationIPC:C07K14/81
[2008/17]
CPC:
C07K14/8125 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/17]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
RSNot yet paid
TitleGerman:VERFAHREN ZUR AUFREINIGUNG DES ALPHA-1-PROTEINASE-INHIBITORS (A1PI)[2008/17]
English:METHOD FOR THE PURIFICATION OF ALPHA-1 PROTEINASE INHIBITOR (a1PI)[2009/19]
French:PROCEDE DE PURIFICATION D'UN INHIBITEUR DE L'ALPHA-1 PROTEINASE (A1PI)[2008/52]
Former [2008/17]METHOD FOR THE PURIFCATION OF ALPHA-1 PROTEINASE INHIBITOR (a1PI)
Former [2008/17]PROCÉDÉ DE PURIFICATION D'UN INHIBITEUR DE L'ALPHA-1 PROTÉINASE (A1PI)
Entry into regional phase10.01.2008National basic fee paid 
10.01.2008Designation fee(s) paid 
10.01.2008Examination fee paid 
Examination procedure10.01.2008Examination requested  [2008/17]
06.06.2008Despatch of a communication from the examining division (Time limit: M04)
09.07.2008Reply to a communication from the examining division
14.08.2008Despatch of a communication from the examining division (Time limit: M04)
07.10.2008Reply to a communication from the examining division
27.11.2008Communication of intention to grant the patent
26.03.2009Fee for grant paid
26.03.2009Fee for publishing/printing paid
Opposition(s)16.02.2010No opposition filed within time limit [2010/16]
Fees paidRenewal fee
25.08.2008Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipBE13.05.2009
CY13.05.2009
CZ13.05.2009
DK13.05.2009
EE13.05.2009
FI13.05.2009
LT13.05.2009
LV13.05.2009
NL13.05.2009
PL13.05.2009
RO13.05.2009
SI13.05.2009
SK13.05.2009
TR13.05.2009
IE09.08.2009
LU09.08.2009
BG13.08.2009
SE13.08.2009
GR14.08.2009
MC31.08.2009
IS13.09.2009
PT13.09.2009
HU14.11.2009
[2011/44]
Former [2011/33]BE13.05.2009
CZ13.05.2009
DK13.05.2009
EE13.05.2009
FI13.05.2009
LT13.05.2009
LV13.05.2009
NL13.05.2009
PL13.05.2009
RO13.05.2009
SI13.05.2009
SK13.05.2009
IE09.08.2009
LU09.08.2009
BG13.08.2009
SE13.08.2009
GR14.08.2009
MC31.08.2009
IS13.09.2009
PT13.09.2009
HU14.11.2009
Former [2011/22]BE13.05.2009
CZ13.05.2009
DK13.05.2009
EE13.05.2009
FI13.05.2009
LT13.05.2009
LV13.05.2009
NL13.05.2009
PL13.05.2009
RO13.05.2009
SI13.05.2009
SK13.05.2009
IE09.08.2009
LU09.08.2009
BG13.08.2009
SE13.08.2009
GR14.08.2009
MC31.08.2009
IS13.09.2009
PT13.09.2009
Former [2011/18]BE13.05.2009
CZ13.05.2009
DK13.05.2009
EE13.05.2009
FI13.05.2009
LT13.05.2009
LV13.05.2009
NL13.05.2009
PL13.05.2009
RO13.05.2009
SI13.05.2009
SK13.05.2009
IE09.08.2009
BG13.08.2009
SE13.08.2009
GR14.08.2009
MC31.08.2009
IS13.09.2009
PT13.09.2009
Former [2011/05]BE13.05.2009
CZ13.05.2009
DK13.05.2009
EE13.05.2009
FI13.05.2009
LT13.05.2009
LV13.05.2009
NL13.05.2009
PL13.05.2009
SI13.05.2009
SK13.05.2009
IE09.08.2009
BG13.08.2009
SE13.08.2009
GR14.08.2009
MC31.08.2009
IS13.09.2009
PT13.09.2009
Former [2010/42]BE13.05.2009
CZ13.05.2009
DK13.05.2009
EE13.05.2009
FI13.05.2009
LT13.05.2009
LV13.05.2009
NL13.05.2009
PL13.05.2009
SI13.05.2009
SK13.05.2009
IE09.08.2009
BG13.08.2009
SE13.08.2009
MC31.08.2009
IS13.09.2009
PT13.09.2009
Former [2010/19]BE13.05.2009
CZ13.05.2009
DK13.05.2009
EE13.05.2009
FI13.05.2009
LT13.05.2009
LV13.05.2009
NL13.05.2009
PL13.05.2009
SI13.05.2009
SK13.05.2009
BG13.08.2009
SE13.08.2009
MC31.08.2009
IS13.09.2009
PT13.09.2009
Former [2010/16]BE13.05.2009
CZ13.05.2009
DK13.05.2009
EE13.05.2009
FI13.05.2009
LT13.05.2009
LV13.05.2009
NL13.05.2009
PL13.05.2009
SI13.05.2009
SK13.05.2009
SE13.08.2009
MC31.08.2009
IS13.09.2009
PT13.09.2009
Former [2010/14]BE13.05.2009
CZ13.05.2009
DK13.05.2009
EE13.05.2009
FI13.05.2009
LT13.05.2009
LV13.05.2009
NL13.05.2009
PL13.05.2009
SI13.05.2009
SK13.05.2009
SE13.08.2009
IS13.09.2009
PT13.09.2009
Former [2010/04]FI13.05.2009
LT13.05.2009
LV13.05.2009
NL13.05.2009
PL13.05.2009
SI13.05.2009
SE13.08.2009
IS13.09.2009
PT13.09.2009
Cited inInternational search[AD]WO9535306  (ALPHA THERAPEUTIC CORP [US]) [AD] 1-24* the whole document *;
 [DA]WO9800154  (ALPHA THERAPEUTIC CORP [US], et al) [DA] 1-24 * the whole document *;
 [XD]  - M H COAN ET AL., "Preparation and properties of alpha-1-proteinase inhibitor concentrate from human plasma", VOX SANGUINIS., CH S. KARGER AG, BASEL., (1985), vol. 48, pages 333 - 342, XP002940191 [XD] 1-24 * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.